The Impact of Acute Pain on Sleep Parameters in the Insomnia Population and Healthy Controls

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-60
SponsorThe Hong Kong Polytechnic University

About this trial

This study investigates how acute exercise-induced muscular pain affects sleep quality and sleep architecture in people with insomnia compared to healthy sleepers.

Sleep disturbances and pain often influence each other, creating a negative cycle; however, it remains unclear how acute muscle pain - such as delayed-onset muscle soreness (DOMS) after strenuous exercise - alters continuous sleep parameters and pain sensitivity differently in clinical insomnia populations versus healthy controls.

Participants will be divided into two groups: individuals with clinical insomnia and age- and sex-matched healthy sleepers. Both groups will undergo a standardized exercise protocol designed to safely induce temporary, acute muscular soreness (DOMS). Objective sleep parameters (measured via wrist Actigraphy) and subjective sleep parameters (measured via sleep diaries), will be monitored before and after the pain induction. The primary goal is to determine whether individuals with insomnia experience greater sleep disruption and altered pain recovery trajectories following an acute painful event compared to healthy individuals.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Adults aged 18 to 60 years

Right-hand and right-foot dominant

Disqualifiers

History of any chronic musculoskeletal pain or presence of existing pain during recruitment

Previous major injuries or surgery involving the lower limbs

Sleep disorders other than insomnia

Clinically diagnosed psychiatric disorders

Trial population

Healthy Adult with or without insomnia

Trial design

Design model

Case-control

Time perspective

Prospective

Treatments tested in this trial

  • Eccentric exercise

    Other intervention

    Eccentric exercise

Treatment groups

80 Participants
are divided into 2 treatment groups
Group A: Insomnia1 intervention
Group B: Healthy contry1 intervention

Trial outcomes

Primary outcomes

1

Sleep diary: Total Sleep Time

Assessed using a daily consensus sleep diary. Total Sleep Time is calculated as the total time spent asleep, derived from the total time in bed (bedtime to wake time) minus sleep onset latency and wake after sleep onset. Higher values indicate longer sleep duration.

Time frame
Day 0 to Day 14
2

Sleep diary: Sleep Onset Latency (SOL)

Assessed using a daily consensus sleep diary. Sleep Onset Latency is the estimated time (in minutes) it takes to fall asleep after turning off the lights. Lower values indicate better sleep onset.

Time frame
Day 0 to Day 14
3

Sleep diary: Wake After Sleep Onset (WASO)

Assessed using a daily consensus sleep diary. WASO is calculated as the total duration of wakefulness (in minutes) between initial sleep onset and final awakening, derived from the number of night awakenings multiplied by their average duration. Lower values indicate better sleep continuity.

Time frame
Day 0 to Day 14
4

Sleep diary: Sleep Efficiency (SE)

Assessed using a daily consensus sleep diary. Sleep Efficiency is calculated as the percentage of time in bed spent asleep: \[(Total Sleep Time / Total Time in Bed) × 100\]. Total Sleep Time is derived from total time in bed (time between bedtime and rise time) minus sleep onset latency and nocturnal wakefulness (calculated from the number and duration of night awakenings). Scores range from 0% to 100%, with higher percentages indicating better sleep quality.

Time frame
Day 0 to Day 14

Secondary outcomes

1

Muscle damage severity: Muscle pain

Muscle pain will be measured by an 11-point NRS, with 0 represents "no pain" and 10 indicating "worst imaginable pain". The Outcome will be recorded at rest, reach for the floor with knees straight, and during a validated hamstring provocative manoeuvre, the "taking-off shoe" test.

Time frame
Day 0 to Day 14
2

Muscle damage severity: Muscle soreness

Muscle soreness will be measured by an 7-point Likert scale, with 0= A complete absence of soreness," 1 = "A light soreness in the muscle felt only when touched/a vague ache," 2 = "A moderate soreness felt only when touched/a slight persistent pain," 3 = "A light muscle soreness when walking up and down stairs," 4 = "A light muscle soreness when walking on flat surface," 5 = "A moderate muscle soreness, stiffness, or weakness when walking," 6 = "A severe muscle soreness, stiffness, or weakness that limits my ability to move."

Time frame
Day 0 to Day 14
3

Sleep Questionnaires: the Insomnia Severity Index (ISI)

The ISI is a 7-item self-report questionnaire assessing the nature, severity, and impact of insomnia. Each item is rated on a 5-point Likert scale (0 to 4). The total score ranges from 0 to 28, with higher scores indicating greater severity of insomnia

Time frame
Day 0 and Day 7
4

Sleep Questionnaires: The Pittsburgh Sleep Quality Index (PSQI)

The PSQI is a 19-item self-report questionnaire that evaluates sleep quality and disturbances over a 1-month time interval. It generates seven component scores: subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleep medication, and daytime dysfunction. Each component is scored from 0 to 3. The sum of these seven component scores yields a global PSQI score ranging from 0 to 21, where higher scores indicate poorer sleep quality.

Time frame
Day 0 and Day 7

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.